Press release
Lyme Disease Therapeutics Market Size Statistics, Facts and Figures
Lyme disease is a contagious disease caused by a bacterium species called Borrelia burgdorferi. It is a tick-borne disease caused by transmission of bacteria to humans through the bite of infected ticks. Common indications of Lyme disease include flu-like symptoms, depression, fatigue, and expanding, circular, reddish skin rashes.
View Report : https://www.transparencymarketresearch.com/lyme-disease-therapeutics-market.html
If left untreated, these symptoms may worsen and can lead to partial or complete loss of facial movement, severe headache, stiffness in the neck, joint pain and swelling, irregular heartbeats, etc. The patient may also, sometimes, develop tingling or shooting pain in the extremities. If the disease is diagnosed at an early stage, it can be treated with antibiotics. However, if left unattended, it may affect the heart, the joints, and the central nervous system, ultimately leading to death.
The global Lyme disease therapeutics market is projected to expand at a significant pace during the forecast period, owing to rise in the rate of incidence of Lyme disease across the globe and continuous R&D activities for the development of vaccines for Lyme disease.
Key Drivers of Global Lyme Disease Therapeutics Market
Unmet medical needs with respect to the treatment of Lyme disease, led by variations in Borrelia burgdorferi genotypes, limit complete cure of the disease. Innovations are underway in the pharmaceutical industry in the area of vaccine candidates. This is expected to increase the rate of prevention of Lyme disease in the near future. The continuing need for reinventing the drug pipeline, led by bacterial mutation and resistance, serves as an opportunity for the global Lyme disease therapeutics market.
Get PDF Sample Copy of Report: (Including TOC, List of Tables & Figures, Chart) : https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76335
Restraints of Global Lyme Disease Therapeutics Market
Pathways to the approval for Lyme disease drugs from regulatory bodies have become confusing, generally infeasible, and questionably irrelevant to patients and providers over a period of time. Additionally, scientific and regulatory challenges significantly increase the cost of and time required for drug development, which greatly worsens economic disadvantages of Lyme disease drugs.
In view of the urgency of bacterial drug resistance and the capacity of targeted disease to change rapidly over time, regulatory bodies are not in favor of revision and streamlining of the anti-bacterial drug development and approval process
REQUEST FOR COVID19 IMPACT ANALYSIS - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76335
North America to Account for a Major Share of Global Lyme Disease Therapeutics Market
North America is likely to dominate the global Lyme disease therapeutics market during the forecast period, due to high rate of incidence of Lyme disease and high awareness about and adoption of new diagnostic methods in the region. According to the Centers for Disease Control and Prevention (CDC), Lyme is one of the most common infectious diseases in North America and around 300,000 people in the region get infected with the disease every year.
The Lyme disease therapeutics market in Asia Pacific is expected to expand at a significant CAGR during the forecast period, owing to rise in the demand for Lyme disease diagnostics in developing nations in the region. Moreover, rise in government and private initiatives to spread awareness regarding bacteria-borne health conditions are anticipated to drive the market in Asia Pacific during the forecast period.
Buy Now Report : https://www.transparencymarketresearch.com/checkout.php?rep_id=76335<ype=S
Key Players Operating in Global Lyme Disease Therapeutics Market
Major players operating in the global Lyme disease therapeutics market are:
Pfizer Inc.
Teva Pharmaceutical Industries, Ltd.
Lupin Pharmaceuticals, Inc.
Mylan N.V.
Sun Pharmaceutical Industries Ltd
GlaxoSmithKline Plc
Valneva SE
Sanofi
Global Lyme Disease Therapeutics Market: Research Scope
Global Lyme Disease Therapeutics Market, by Treatment Type
Medication
Tick Removal
Global Lyme Disease Therapeutics Market, by Drug
Antibiotics
Doxycycline
Amoxicillin
Others
Vaccines
Global Lyme Disease Therapeutics Market, by Dosage Form
Oral
Intravenous
Topical
Global Lyme Disease Therapeutics Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
More Trending Reports by Transparency Market Research - 1. http://www.prnewswire.com/news-releases/despite-several-factors-supporting-osteoporosis-drugs-market-patent-expiration-of-blockbuster-drugs-to-hamper-markets-progress-tmr-301019711.html
2. https://www.biospace.com/article/bone-growth-stimulators-market-personalized-electric-stimulation-devices-gain-prominence-in-market/
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lyme Disease Therapeutics Market Size Statistics, Facts and Figures here
News-ID: 2055430 • Views: …
More Releases from Transparency Market Research
Global Clinical Trial Investigative Site Network Market Set to Reach USD 18.7 Bi …
The global Clinical Trial Investigative Site Network Market is witnessing steady expansion as pharmaceutical, biotechnology, and medical device companies intensify their clinical development efforts worldwide. Valued at US$ 9.2 billion in 2025, the market is projected to nearly double and reach US$ 18.7 billion by 2036, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2036. This growth trajectory reflects the increasing complexity of clinical trials,…
Enteral Feeding Devices Market to Reach US$ 8.1 Billion by 2036: Size, Growth Dr …
The global enteral feeding devices market was valued at US$ 4.7 Bn in 2025 and is projected to reach US$ 8.1 Bn by 2036, expanding at a CAGR of 5.1% from 2026 to 2036. This steady expansion reflects the growing reliance on clinical and home-based nutritional support solutions for patients unable to meet dietary needs orally. Rising awareness of nutrition therapy, an aging global population, and the rapid growth of…
Automotive Battery Management System (BMS) Market Expanding at 16.0% CAGR Throug …
The global Automotive Battery Management System (BMS) market was valued at US$ 6.7 billion in 2025 and is projected to expand significantly to US$ 31.1 billion by 2036, registering a robust compound annual growth rate (CAGR) of 16.0% during the forecast period from 2026 to 2036. This strong growth trajectory highlights the rising strategic importance of BMS solutions as electric and hybrid vehicles become central to the global automotive ecosystem.
Get…
Autonomous Vehicle Market Outlook 2036: Global Industry Set to Explode from US$ …
The global autonomous vehicle market is undergoing a historic transformation as automation, artificial intelligence, and advanced sensor technologies redefine the future of mobility. Valued at US$ 203.5 billion in 2025, the market is projected to surge to an exceptional US$ 2,208.2 billion by 2036, expanding at a remarkable CAGR of 25% from 2026 to 2036. This exponential growth reflects the rapid shift toward self-driving technologies across passenger vehicles, commercial fleets,…
More Releases for Lyme
Lyme Disease Diagnostics Market Projected to Show Strong Growth
Advance Market Analytics published a new research publication on "Lyme Disease Diagnostics Market Insights, to 2033" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Lyme Disease Diagnostics market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample…
Lyme Disease - Drug Pipeline Landscape, 2022
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash.
Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems.
To know more about Lyme Disease - Drug Pipeline ,…
Lyme Disease - Drug Pipeline Landscape, 2022 | Global Insight Services
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. Diagnosis of Lyme disease involves lab tests to…
Lyme Disease Vaccines - Are They Effective?| Valneva, GlaxoSmithKline Plc.
There is currently no Lyme disease vaccine available. LYMERix®, the only vaccine previously marketed in the United States, was withdrawn from the market in 2002 due to a lack of consumer demand. The vaccine's effectiveness deteriorates over time.
Lyme Disease Vaccines Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing…
Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
…
As Lyme Disease Cases Expected To Soar In 2017, Global Lyme Diagnostics Introduc …
A recent piece on NBC News With Lester Holt presented some startling facts regarding Lyme Disease. Cases of Lyme Disease are up 500% in Michigan alone. Lyme Disease is spreading across the US and we can expect to see the number of patients infected increase in 2017.
As published in the journal Science, Lyme disease carrying ticks are now present in half the counties in the United States. In many…
